• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Sporadic inclusion body myositis: variability in prevalence and phenotype and influence of the MHC.散发性包涵体肌炎:患病率和表型的变异性以及主要组织相容性复合体的影响
Acta Myol. 2009 Oct;28(2):66-71.
2
Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3.两种主要组织相容性复合体单倍型影响散发性包涵体肌炎的易感性:对与HLA - DR3关联的批判性评估
Tissue Antigens. 2004 Nov;64(5):575-80. doi: 10.1111/j.1399-0039.2004.00310.x.
3
The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype.HLA-DR3和8.1 MHC祖传单倍型携带者中散发性包涵体肌炎与干燥综合征的关联。
Clin Neurol Neurosurg. 2011 Sep;113(7):559-63. doi: 10.1016/j.clineuro.2011.03.016. Epub 2011 Apr 20.
4
Recombination mapping of the susceptibility region for sporadic inclusion body myositis within the major histocompatibility complex.散发性包涵体肌炎易感性区域与主要组织相容性复合体的重组图谱定位。
J Neuroimmunol. 2011 Jun;235(1-2):77-83. doi: 10.1016/j.jneuroim.2011.02.011. Epub 2011 May 2.
5
Familial inclusion body myositis in a mother and son with different ancestral MHC haplotypes.一位母亲和儿子患有不同祖传主要组织相容性复合体单倍型的家族性包涵体肌炎。
Neuromuscul Disord. 2006 Nov;16(11):754-8. doi: 10.1016/j.nmd.2006.06.009. Epub 2006 Aug 28.
6
Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases.散发性包涵体肌炎:57例澳大利亚病例队列中的表型变异性及HLA - DR3的影响
J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1056-60. doi: 10.1136/jnnp.2007.138891. Epub 2008 Feb 7.
7
Sporadic inclusion body myositis in Japanese is associated with the MHC ancestral haplotype 52.1.日本散发性包涵体肌炎与MHC祖先单倍型52.1相关。
Neuromuscul Disord. 2006 May;16(5):311-5. doi: 10.1016/j.nmd.2006.02.002. Epub 2006 Mar 24.
8
Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype.散发性包涵体肌炎:HLA-DRB1 等位基因相互作用影响疾病风险和临床表型。
Neuromuscul Disord. 2009 Nov;19(11):763-5. doi: 10.1016/j.nmd.2009.07.015. Epub 2009 Aug 31.
9
Mapping of a candidate region for susceptibility to inclusion body myositis in the human major histocompatibility complex.人类主要组织相容性复合体中包涵体肌炎易感性候选区域的定位
Immunogenetics. 1999 Jun;49(6):508-16. doi: 10.1007/s002510050528.
10
Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis.散发性包涵体肌炎的患病率及导致诊断延迟的因素。
J Clin Neurosci. 2008 Dec;15(12):1350-3. doi: 10.1016/j.jocn.2008.01.011. Epub 2008 Sep 23.

引用本文的文献

1
Inflammasome in Skeletal Muscle: NLRP3 Is an Inflammatory Cell Stress Component in Inclusion Body Myositis.炎症小体在骨骼肌中的作用:NLRP3 是包涵体肌炎中炎性细胞应激的组成部分。
Int J Mol Sci. 2023 Jun 26;24(13):10675. doi: 10.3390/ijms241310675.
2
A Comprehensive Review of Autophagy and Its Various Roles in Infectious, Non-Infectious, and Lifestyle Diseases: Current Knowledge and Prospects for Disease Prevention, Novel Drug Design, and Therapy.自噬及其在感染性、非感染性和生活方式疾病中的多种作用的综合综述:疾病预防、新型药物设计和治疗的现有知识和前景。
Cells. 2019 Jul 3;8(7):674. doi: 10.3390/cells8070674.
3
Inclusion body myositis: therapeutic approaches.包涵体肌炎:治疗方法。
Degener Neurol Neuromuscul Dis. 2012 May 10;2:43-52. doi: 10.2147/DNND.S19899. eCollection 2012.
4
New Developments in the Genetics of Inclusion Body Myositis.包涵体肌炎遗传学的新进展。
Curr Rheumatol Rep. 2018 Apr 2;20(5):26. doi: 10.1007/s11926-018-0738-0.
5
Immune and myodegenerative pathomechanisms in inclusion body myositis.包涵体肌炎中的免疫和肌肉退行性病变发病机制。
Ann Clin Transl Neurol. 2017 May 16;4(6):422-445. doi: 10.1002/acn3.419. eCollection 2017 Jun.
6
Inclusion body myositis - pathomechanism and lessons from genetics.包涵体肌炎——发病机制及遗传学启示
Open Med (Wars). 2015 Feb 26;10(1):188-193. doi: 10.1515/med-2015-0030. eCollection 2015.
7
Development and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositis.用于检测散发性包涵体肌炎中抗cN-1A(Mup44,NT5C1A)自身抗体的标准化酶联免疫吸附测定法的开发与评估
Auto Immun Highlights. 2016 Dec;7(1):16. doi: 10.1007/s13317-016-0088-8. Epub 2016 Nov 17.
8
Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USA.散发性包涵体肌炎患者的死亡率和死因:基于澳大利亚、欧洲和美国专家临床经验的调查研究。
J Neuromuscul Dis. 2016 Mar 3;3(1):67-75. doi: 10.3233/JND-150138.
9
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies.特发性炎性肌病的临床和组织学谱。
Clin Rev Allergy Immunol. 2017 Feb;52(1):88-98. doi: 10.1007/s12016-015-8517-4.
10
Emerging therapeutic options for sporadic inclusion body myositis.散发性包涵体肌炎的新兴治疗选择
Ther Clin Risk Manag. 2015 Sep 25;11:1459-67. doi: 10.2147/TCRM.S65368. eCollection 2015.

本文引用的文献

1
Sporadic-inclusion body myositis (s-IBM) is not so prevalent in Istanbul/Turkey: a muscle biopsy based survey.散发性包涵体肌炎(s-IBM)在土耳其伊斯坦布尔并不常见:一项基于肌肉活检的调查。
Acta Myol. 2011 Jun;30(1):34-6.
2
Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype.散发性包涵体肌炎:HLA-DRB1 等位基因相互作用影响疾病风险和临床表型。
Neuromuscul Disord. 2009 Nov;19(11):763-5. doi: 10.1016/j.nmd.2009.07.015. Epub 2009 Aug 31.
3
Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis.阿仑单抗(CAMPATH 1-H)对包涵体肌炎患者的疗效。
Brain. 2009 Jun;132(Pt 6):1536-44. doi: 10.1093/brain/awp104. Epub 2009 May 19.
4
Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains.包涵体肌炎:肌纤维分子病理学及其与阿尔茨海默病和帕金森病脑相似性的可能致病意义。
Acta Neuropathol. 2008 Dec;116(6):583-95. doi: 10.1007/s00401-008-0449-0. Epub 2008 Oct 31.
5
Study of idiopathic inflammatory myopathies with special reference to borderland between idiopathic inflammatory myopathies and muscular dystrophies.特发性炎性肌病的研究,特别涉及特发性炎性肌病与肌营养不良症之间的界限。
Neurol India. 2008 Jul-Sep;56(3):356-62. doi: 10.4103/0028-3886.43456.
6
Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis.散发性包涵体肌炎的患病率及导致诊断延迟的因素。
J Clin Neurosci. 2008 Dec;15(12):1350-3. doi: 10.1016/j.jocn.2008.01.011. Epub 2008 Sep 23.
7
Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle.散发性包涵体肌炎中炎症与淀粉样前体蛋白的相互关系:白细胞介素-1β诱导骨骼肌中β-淀粉样蛋白的积累。
Brain. 2008 May;131(Pt 5):1228-40. doi: 10.1093/brain/awn053. Epub 2008 Apr 17.
8
Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases.散发性包涵体肌炎:57例澳大利亚病例队列中的表型变异性及HLA - DR3的影响
J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1056-60. doi: 10.1136/jnnp.2007.138891. Epub 2008 Feb 7.
9
Sporadic inclusion body myositis: a continuing puzzle.散发性包涵体肌炎:一个持续存在的谜题。
Neuromuscul Disord. 2008 Jan;18(1):6-16. doi: 10.1016/j.nmd.2007.11.001. Epub 2007 Dec 21.
10
Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications.炎性肌病的免疫模型及潜在治疗意义
Neurology. 2007 Nov 20;69(21):2008-19. doi: 10.1212/01.WNL.0000291619.17160.b8. Epub 2007 Oct 10.

散发性包涵体肌炎:患病率和表型的变异性以及主要组织相容性复合体的影响

Sporadic inclusion body myositis: variability in prevalence and phenotype and influence of the MHC.

作者信息

Mastaglia F L

机构信息

Centre for Neuromuscular and Neurological Disorders, University of Western Australia.

出版信息

Acta Myol. 2009 Oct;28(2):66-71.

PMID:20128139
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2858953/
Abstract

Sporadic inclusion body myositis (sIBM) is the most common myopathy presenting over the age of 40 years but its prevalence varies considerably in different populations. Genetic factors play a part in the pathogenesis of sIBM and in Caucasians susceptibility has been linked to the HLA-DR3 allele and the 8.1 MHC ancestral haplotype (AH) which is also associated with other autoimmune diseases. The variable prevalence of sIBM in different populations may be related to differences in the population frequency of this haplotype. Our recent observations indicate that the clinical phenotype at presentation is also quite variable and that the influence of the MHC is more complex than previously appreciated with HLA alleles also having modifying effects on the age-at-onset, severity and rate of progression of the disease. Recent recombinant mapping studies of polymorphisms in the Class II/III regions of the MHC by our group have further refined the susceptibility region and have identified a number of candidate genes warranting further investigation. The significance of these findings for the pathogenesis of the disease is discussed.

摘要

散发性包涵体肌炎(sIBM)是40岁以上人群中最常见的肌病,但其患病率在不同人群中差异很大。遗传因素在sIBM的发病机制中起作用,在白种人中,易感性与HLA - DR3等位基因和8.1 MHC祖传单倍型(AH)有关,该单倍型也与其他自身免疫性疾病相关。sIBM在不同人群中的患病率差异可能与该单倍型在人群中的频率差异有关。我们最近的观察表明,发病时的临床表型也相当多变,而且MHC的影响比以前认为的更复杂,HLA等位基因对疾病的发病年龄、严重程度和进展速度也有调节作用。我们小组最近对MHC II/III类区域多态性的重组图谱研究进一步细化了易感区域,并确定了一些值得进一步研究的候选基因。讨论了这些发现对疾病发病机制的意义。